| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |